New immunotherapy combination tolerable, effective in patients with advanced kidney cancer – Medical Xpress
Medical Xpress |
New immunotherapy combination tolerable, effective in patients with advanced kidney cancer
Medical Xpress The immunotherapy agent, pembrolizumab, is an immune checkpoint inhibitor that blocks a self-defense mechanism used by cancer cells to evade attack and destruction by the body's immune cells. It is FDA-approved for the treatment of patients with … New combo therapy found effective in kidney cancer patients |
